New Diagnostic and Treatment Methods for Tuberculosis in Ukraine
Ukraine is implementing a major overhaul of its tuberculosis (TB) strategy, shifting from the traditional Mantoux test to more effective Interferon-Gamma Release Assays (IGRAs). This transition to new skin tests, which will begin a gradual rollout across all regions in April 2024, promises more sensitive and reliable detection of the disease, particularly in children. This move aligns Ukraine with modern global healthcare standards for TB control.
The new program will also utilize GeneXpert equipment, capable of diagnosing TB in just four hours. This drastically cuts waiting times for results and allows for faster treatment initiation. Furthermore, the standard treatment course will be shortened to 6-9 months, down from the previous 18 months. These improvements have already contributed to a rise in patient recovery rates from 50% in 2017 to 72-75% currently, with 70% of patients now receiving outpatient care. All these services remain free of charge for the population.
Revised Schedule for BCG Vaccination
A revised BCG vaccination schedule is another key component of the new program. Starting January 1, 2026, infants are planned to receive the vaccine within 24 hours of birth, instead of the traditional 3-5 days. This aims to provide earlier protection against TB at a critical stage of life.
The war in Ukraine has exacerbated the spread of infectious diseases like tuberculosis, underscoring the urgency of these new diagnostic and treatment methods. As Volodymyr Kurpita noted,
"The interferon-gamma release test allows for the detection of tuberculosis, especially in children, significantly more effectively and with higher quality than was previously possible."
In a related move to strengthen the healthcare system, Ukraine's National Health Service (NHSU) has decided to suspend payments to medical institutions that failed to provide justifications for their doctors working across multiple facilities. This highlights broader efforts to improve accountability within the health system amid current challenges.
The introduction of modern TB diagnostics and treatments in Ukraine represents a critical step in combating the disease, especially as its prevalence has increased during the war. Shortened therapy duration and faster diagnosis can significantly improve treatment outcomes and reduce the burden on the medical system. The changes to the vaccination schedule further emphasize the importance of early prevention, which can help reduce transmission risks among newborns.
As Ukraine enhances its tuberculosis detection methods, the importance of timely immunization becomes even more evident. The introduction of a revised BCG vaccination schedule for newborns is set to play a crucial role in combating TB from an early age. This initiative follows the recent acquisition of BCG vaccine doses, ensuring that infants receive essential protection against the disease within 24 hours of birth. Such proactive measures are vital to safeguard the health of future generations.